Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Collen

Showing results (331-340 of 715) with videos related to

Pageof 72
Sort By:
Thrombosis Research|September 1, 1985
Modification of a tyrosine residue in the carboxyterminal portion of human alpha2-antiplasminH R Lijnen, B Van Hoef, B Wiman, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 26, 1998
LDL hypercholesterolemia is associated with accumulation of oxidized LDL, atherosclerotic plaque growth, and compensatory vessel enlargement in coronary arteries of miniature pigsP Holvoet, G Theilmeier, B Shivalkar, et al.
The Journal of Biological Chemistry|April 25, 1987
Characterization of recombinant human single chain urokinase-type plasminogen activator mutants produced by site-specific mutagenesis of lysine 158L Nelles, H R Lijnen, D Collen, et al.
Genesis (New York, N.Y. : 2000)|February 22, 2002
Generation of Pex5-loxP mice allowing the conditional elimination of peroxisomesM Baes, M Dewerchin, A Janssen, et al.
Analytical Biochemistry|August 1, 1997
Nonisotopic quantitative analysis of protein-DNA interactions at equilibriumA M Benotmane, M F Hoylaerts, D Collen, et al.
The Journal of Biological Chemistry|February 5, 1987
Primary structure of human alpha 2-antiplasmin, a serine protease inhibitor (serpin)W E Holmes, L Nelles, H R Lijnen, et al.
The Journal of Clinical Investigation|June 1, 1972
Metabolism of plasminogen in healthy subjects: effect of tranexamic acidD Collen, G Tytgat, H Claeys, et al.
The Journal of Clinical Investigation|July 1, 1986
Influence of the fast-acting inhibitor of plasminogen activator on in vivo thrombolysis induced by tissue-type plasminogen activator in rabbits. Interference of tissue-derived componentsM Colucci, J A Paramo, J M Stassen, et al.
Blood|January 15, 1997
The amino terminal lectin-like domain of thrombomodulin is required for constitutive endocytosisE M Conway, S Pollefeyt, D Collen, et al.
The Journal of Clinical Investigation|January 15, 1997
Impaired arterial neointima formation in mice with disruption of the plasminogen geneP Carmeliet, L Moons, V Ploplis, et al.
Pageof 72

Showing results (331-340 of 715) with videos related to

Sort By:
Pageof 72
Thrombosis Research|September 1, 1985
Modification of a tyrosine residue in the carboxyterminal portion of human alpha2-antiplasminH R Lijnen, B Van Hoef, B Wiman, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 26, 1998
LDL hypercholesterolemia is associated with accumulation of oxidized LDL, atherosclerotic plaque growth, and compensatory vessel enlargement in coronary arteries of miniature pigsP Holvoet, G Theilmeier, B Shivalkar, et al.
The Journal of Biological Chemistry|April 25, 1987
Characterization of recombinant human single chain urokinase-type plasminogen activator mutants produced by site-specific mutagenesis of lysine 158L Nelles, H R Lijnen, D Collen, et al.
Genesis (New York, N.Y. : 2000)|February 22, 2002
Generation of Pex5-loxP mice allowing the conditional elimination of peroxisomesM Baes, M Dewerchin, A Janssen, et al.
Analytical Biochemistry|August 1, 1997
Nonisotopic quantitative analysis of protein-DNA interactions at equilibriumA M Benotmane, M F Hoylaerts, D Collen, et al.
The Journal of Biological Chemistry|February 5, 1987
Primary structure of human alpha 2-antiplasmin, a serine protease inhibitor (serpin)W E Holmes, L Nelles, H R Lijnen, et al.
The Journal of Clinical Investigation|June 1, 1972
Metabolism of plasminogen in healthy subjects: effect of tranexamic acidD Collen, G Tytgat, H Claeys, et al.
The Journal of Clinical Investigation|July 1, 1986
Influence of the fast-acting inhibitor of plasminogen activator on in vivo thrombolysis induced by tissue-type plasminogen activator in rabbits. Interference of tissue-derived componentsM Colucci, J A Paramo, J M Stassen, et al.
Blood|January 15, 1997
The amino terminal lectin-like domain of thrombomodulin is required for constitutive endocytosisE M Conway, S Pollefeyt, D Collen, et al.
The Journal of Clinical Investigation|January 15, 1997
Impaired arterial neointima formation in mice with disruption of the plasminogen geneP Carmeliet, L Moons, V Ploplis, et al.
Pageof 72